Get started
Author

Vassiliki Douka

Splenic Marginal-zone Lymphoma: One or More Entities? A Histologic, Immunohistochemical, and Molecular Study of 42 Cases
2007 · Theodora Papadaki, Kostas Stamatopoulos, et al. · The American Journal of Surgical Pathology · 53
Immunoglobulin Heavy- And Light-chain Repertoire in Splenic Marginal Zone Lymphoma
2004 · Kostas Stamatopoulos, Chrysoula Belessi, et al. · Molecular Medicine · 53
PDF
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
2021 · Christos Demosthenous, Ioanna Sakellari, et al. · Journal of Clinical Medicine · 40
PDF
Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study
2018 · Ioanna Sakellari, Eleni Gavriilaki, et al. · Annals of Hematology · 34
Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia
2005 · Tatjana Smilevska, Kostas Stamatopoulos, et al. · Leukemia Research · 34
IgG-Switched CLL Has a Distinct Immunogenetic Signature from the Common MD Variant: Ontogenetic Implications
2013 · Anna Vardi, Andreas Agathangelidis, et al. · Clinical Cancer Research · 33
PDF
Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment
2018 · Christos Demosthenous, Chrysavgi Lalayanni, et al. · Current Problems in Cancer · 26
An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit
2013 · Aliki Ioakimidou, Timoleon-Achilleas Vyzantiadis, et al. · Diagnostic Microbiology and Infectious Disease · 24
Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study
2023 · S. Chatzileontiadou, E. Hatjiharissi, et al. · Frontiers in Oncology · 23
PDF
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
2018 · Eirini Katodritou, Marie-Christine Kyrtsonis, et al. · Annals of Hematology · 20
PDF
Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas
2015 · Ioanna Sakellari, Despoina Mallouri, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 19
Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study
2021 · Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al. · Cancers · 16
PDF
Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece
2022 · Eleni Gavriilaki, Athanasios Tragiannidis, et al. · Frontiers in Oncology · 7
PDF
Characteristics and Survival Outcomes of Solitary Plasmacytomas: A 30‐Year Experience of the Greek Myeloma Study Group on 175 Patients
2025 · Eirini Katodritou, Efstathios Kastritis, et al. · American Journal of Hematology · 5
Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change
2020 · Eleni Gavriilaki, Ioanna Sakellari, et al. · HemaSphere · 5
Revisiting Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Combined Clinicobiological Approach
2014 · Panagiotis Baliakas, Aliki Xochelli, et al. · Blood · 5
Tp53gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors
2016 · Katerina Gemenetzi, Chrysi Galigalidou, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group
2024 · Ioannis Ntanasis-Stathopoulos, Eirini Katodrytou, et al. · Blood · 3
PDF
Characteristics, Outcome, and Prognostic Factors for Survival and Progression to Multiple Myeloma of Solitary Plasmacytomas: A 30-Year Experience of the Greek Myeloma Study Group
2024 · Eirini Katodritou, Efstathios Kastritis, et al. · Blood · 1
Pb1894: Npm1 Mutated Acute Myeloid Leukemia: the Co-mutation Patterns May Be Associated With Prognosis
2023 · Christos Varelas, Apostolia Papalexandri, et al. · HemaSphere · 1
Pb1936: Paroxysmal Nocturnal Hemoglobinuria and Thrombosis: a Multicentric Retrospective Study
2022 · S. Chatzileontiadou, N.-E. Loutsidi, et al. · HemaSphere · 1
Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome: Disappearance of cytogenetic abnormalities
2020 · Niki Vyrides, Vassiliki Douka, et al. · Cancer Genetics · 1
Distinct Profiles of in Vivo Class Switch Recombination in Chronic Lymphocytic Leukemia Subsets with Stereotyped B Cell Receptors, Suggestive of Distinct Modes of Activation by Antigen
2012 · Aliki Xochelli, Evangelia Stalika, et al. · Blood · 1
A cluster of bloodstream infections due to Acremonium kiliense in hematopoietic cell transplanted patients
2011 · Nikolaos Malisiovas, Αchilles Anagnostopoulos, et al. · Mycoses · 1
Immunoglobulin Light Chain Repertoire in Chronic Lymphocytic Leukemia (CLL): Recognition of Subsets with “CLL-Specific” CDR3 Regions and Associations with Heavy Chains.
2004 · Kostas Stamatopoulos, Chrysoula Belessi, et al. · Blood · 1
Works count: 46
Citation count: 411
H-index: 12
I10-index: 12
Year
Topic
Type